Table 1.
Clinical characteristics of ECMO survivors vs. nonsurvivors
| Demographic/clinical variables | ECMO survivor (n = 61) | ECMO nonsurvivor (n = 29) | p value |
|---|---|---|---|
| Age, years* | 37.5 (18–57) | 45.6 (16–79) | 0.054 |
| Gender, male | 38 (62.3) | 25 (89.3) | 0.006 |
| Race | |||
| Caucasian | 13 (39.4) | 8 (44.4) | 0.648 |
| Hispanic | 13 (39.4) | 7 (21.2) | |
| ECMO mode (VV) | 53 (86.9) | 20 (71.4) | 0.086 |
| SAPS2* | 58.0 (23–86) | 73.5 (27–92) | 0.023 |
| Oxygenation index* | 42.1 (24.4–77.2) | 44.4 (16.9–99.3) | 0.585 |
| Vasopressor requirement | 21 (77.8) | 14 (73.7) | 0.749 |
| ECMO indication | |||
| ARDS | 49 (80.3) | 19 (67.9) | 0.206 |
| Cardiac failure | 7 (11.5) | 4 (12.5) | 0.711 |
Data presented as n (%) and median (range/IQR).
*
Wilcoxon/KW test.
Comparison of characteristics of ECMO patients by mortality.
VV, venovenous; SAPS2, simplified acute physiology score; ECMO, extracorporeal membrane oxygenation; IQR, interquartile range.